Paras Biopharmaceuticals Finland Oy – Exploring Reverse Merger Opportunity
Paras Biopharmaceuticals Finland Oy is seeking appropriate interest on a Reverse Merger to release its potential. OULU, FINLAND, May 3, 2022 /EINPresswire.com/ — Paras Biopharmaceuticals Finland Oy with a strong track record of developing a unique proprietary technology platform for complex biologics including a high value pipeline of biosimilars and noble biologics, in addition to […]
Read more